Article
Peripheral level of CD33 and Alzheimer's disease: a bidirectional two-sample Mendelian randomization study.
Translational psychiatry - 3 Oct 2022
Gu Xiaojing, Dou Meng, Cao Bei, Jiang Zheng, Chen Yongping
Abstract excerpt
Increased expression of CD33 in the brain has been suggested to be associated with increased amyloid plaque burden, while the peripheral level of CD33 in Alzheimer's disease (AD) patients and its role in AD remain unclear. The current study aimed to systematically explore the bidirectional relationship between peripheral CD33 and AD. Genome-wide association study (GWAS) datasets of AD (Ncases: 21982; Ncontrols:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
